Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder

References

• Ackenheil M, Stotz G, Dietz-Bauer R, Vossen A. 1998. M.I.N.I: International Neuropsychiatric Interview – German Version 5.0.0. Deutschland: München.
   Google Scholar
• Archer T, Josefsson T, Lindwall M. 2014. Effects of physical exercise on depressive symptoms and biomarkers in depression. CNS Neurol Disord Drug Targets. 13:1640–1653.
   PubMed Web of Science ®Google Scholar
• Aschenbrenner A, Tucha O, Lange K, editors. 2000. RWT Regensburger Wortflüssigkeits-Test. Handanweisung. Göttingen: Hogrefe.
   Google Scholar
• Autry AE, Monteggia LM. 2012. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev. 64:238–258.
   PubMed Web of Science ®Google Scholar
• Beblo T, Sinnamon G, Baune BT. 2011. Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors. Neuropsychol Rev. 21:337–359.
   PubMed Web of Science ®Google Scholar
• Becker S, Macqueen G, Wojtowicz JM. 2009. Computational modeling and empirical studies of hippocampal neurogenesis-dependent memory: Effects of interference, stress and depression. Brain Res. 1299:45–54.
   PubMed Web of Science ®Google Scholar
• Becker S, Wojtowicz JM. 2007. A model of hippocampal neurogenesis in memory and mood disorders. Trends Cogn Sci (Regul Ed.). 11:70–76.
   PubMed Web of Science ®Google Scholar
• Begliuomini S, Lenzi E, Ninni F, Casarosa E, Merlini S, Pluchino N, Valentino V, Luisi S, Luisi M, Genazzani AR, et al. 2008. Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol. 197:429–435.
   PubMed Web of Science ®Google Scholar
• Bjorkholm C, Monteggia LM. 2016. BDNF - a key transducer of antidepressant effects. Neuropharmacology. 102:72–79.
   PubMed Web of Science ®Google Scholar
• Bocchio-Chiavetto L, Bagnardi V, Zanardini R, Molteni R, Nielsen MG, Placentino A, Giovannini C, Rillosi L, Ventriglia M, Riva MA, et al. 2010. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J Biol Psychiatry. 11:763–773.
   PubMed Web of Science ®Google Scholar
• Borenstein M, Hedges LV, Higgins JP, Rothstein HR. 2010. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 1:97–111.
   PubMed Web of Science ®Google Scholar
• Bortolato B, Carvalho AF, McIntyre RS. 2014. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review. CNS Neurol Disord Drug Targets. 13:1804–1818.
   PubMed Web of Science ®Google Scholar
• Buttenschøn HN, Demontis D, Kaas M, Elfving B, Mølgaard S, Gustafsen C, Kaerlev L, Petersen CM, Børglum AD, Mors O, et al. 2015. Increased serum levels of sortilin are associated with depression and correlated with BDNF and VEGF. Transl Psychiatry. 5:e677.
   PubMed Web of Science ®Google Scholar
• Cain SW, Chang A-M, Vlasac I, Tare A, Anderson C, Czeisler CA, Saxena R. 2017. Circadian rhythms in plasma brain-derived neuritrophic factor differ in men and women. J Biol Rhythms. 32:75–82.
   PubMed Web of Science ®Google Scholar
• Carvalho AF, Köhler CA, McIntyre RS, Knöchel C, Brunoni AR, Thase ME, Quevedo J, Fernandes BS, Berk M. 2015. Peripheral vascular endothelial growth factor as a novel depression biomarker: a meta-analysis. Psychoneuroendo-crinology. 62:18–26.
   PubMed Web of Science ®Google Scholar
• Chiou YJ, Huang TL. 2017. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: effects of antipsychotics. World J Biol Psychiatry. 18:382–391.
   PubMed Web of Science ®Google Scholar
• Choi S-W, Bhang S, Ahn J-H. 2011. Diurnal variation and gender differences of plasma brain-derived neurotrophic factor in healthy human subjects. Psychiatry Res. 186:427–430.
   PubMed Web of Science ®Google Scholar
• Day JJ, Sweatt JD. 2011. Epigenetic mechanisms in cognition. Neuron. 70:813–829.
   PubMed Web of Science ®Google Scholar
• Day JJ, Sweatt JD. 2012. Epigenetic treatments for cognitive impairments. Neuropsychopharmacology. 37:247–260.
   PubMed Web of Science ®Google Scholar
• Dias VV, Brissos S, Frey BN, Andreazza AC, Cardoso C, Kapczinski F. 2009. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disord. 11:663–671.
   PubMed Web of Science ®Google Scholar
• Dishman RK, Berthoud H-R, Booth FW, Cotman CW, Edgerton VR, Fleshner MR, Gandevia SC, Gomez-Pinilla F, Greenwood BN, Hillman CH, et al. 2006. Neurobiology of exercise. Obesity (Silver Spring). 14:345–356.
   PubMed Web of Science ®Google Scholar
• Elzinga BM, Molendijk ML, Oude Voshaar RC, Bus BAA, Prickaerts J, Spinhoven P, Penninx BJWH. 2011. The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met. Psychopharmacology (Berl). 214:319–328.
   PubMed Web of Science ®Google Scholar
• Fernandes BS, Molendijk ML, Köhler CA, Soares JC, Leite CMGS, Machado-Vieira R, Ribeiro TL, Silva JC, Sales PMG, Quevedo J, et al. 2015. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies. BMC Med. 13:289.
   PubMed Web of Science ®Google Scholar
• Gorwood P. 2008. Neurobiological mechanisms of anhedonia. Dialogues Clin Neurosci. 10:291–299.
   PubMedGoogle Scholar
• Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:56–62.
   PubMed Web of Science ®Google Scholar
• Holm S. 1979. A simple sequentially rejective multiple test procedure. Scand. J. Stat 6:665–670.
   Web of Science ®Google Scholar
• Huang T, Larsen KT, Ried-Larsen M, Moller NC, ndersen LB. 2014. The effects of physical activity and exercise on brain-derived neurotrophic factor in healthy humans: a review. Scand J Med Sci Sports. 24:1–10.
   PubMed Web of Science ®Google Scholar
• Komulainen P, Pedersen M, Hänninen T, Bruunsgaard H, Lakka TA, Kivipelto M, Hassinen M, Rauramaa TH, Pedersen BK, Rauramaa R, et al. 2008. BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study. Neurobiol Learn Mem. 90:596–603.
   PubMed Web of Science ®Google Scholar
• Lamberty GJ, Putnam SH, Chatel DM, Bieliauskas LA, Adams KM. 1994. Derived trail making test indices. Neuropsychiat Neuropsychol Behav Neurol. 7:230–234.
   Google Scholar
• Laske C, Stransky E, Leyhe T, Eschweiler GW, Wittorf A, Richartz E, Bartels M, Buchkremer G, Schott K. 2006. Stage-dependent BDNF serum concentrations in Alzheimer's disease. J Neural Transm (Vienna). 113:1217–1224.
   PubMed Web of Science ®Google Scholar
• Lehrl S. 1969. Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B). Erlangen: Perimed Fachbuch Verlagsgesellschaft mbH.
   Google Scholar
• Lewin J, Schmitt AO, Adorjan P, Hildmann T, Piepenbrock C. 2004. Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics. 20:3005–3012.
   PubMed Web of Science ®Google Scholar
• Lu Y, Christian K, Lu B. 2008. BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory? Neurobiol Learn Mem. 89:312–323.
   PubMed Web of Science ®Google Scholar
• Mamounas LA, Blue ME, Siuciak JA, Altar CA. 1995. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci. 15:7929–7939.
   PubMed Web of Science ®Google Scholar
• Molendijk ML, Bus BAA, Spinhoven P, Penninx BWJH, Kenis G, Prickaerts J, Voshaar RCO, Elzinga BM. 2011. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry. 16:1088–1095.
   PubMed Web of Science ®Google Scholar
• Mössner R, Mikova O, Koutsilieri E, Saoud M, Ehlis A-C, Müller N, Fallgatter AJ, Riederer P. 2007. Consensus paper of the WFSBP task force on biological markers: biological markers in depression. World J Biol Psychiatry. 8:141–174.
   PubMed Web of Science ®Google Scholar
• Murphy M, Sarginson JE, Ryan HS, O´Hara R, Schatzberg AF, Lazzeroni LC. 2013. BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression. Pharmacogenet Genomics. 23:301–313.
   PubMed Web of Science ®Google Scholar
• Nakano Y, Baba H, Maeshima H, Kitajima A, Sakai Y, Baba K, Suzuki T, Mimura M, Arai H. 2008. Executive dysfunction in medicated, remitted state of major depression. J Affect Disord 111:46–51.
   PubMed Web of Science ®Google Scholar
• Neu P, Bajbouj M, Schilling A, Godemann F, Berman RM, Schlattmann P. 2005. Cognitive function over the treatment course of depression in middle-aged patients: correlation with brain MRI signal hyperintensities. J Psychiatr Res. 39:129–135.
   PubMed Web of Science ®Google Scholar
• Nicod J, Wagner S, Vonberg F, Bhomra A, Schlicht KF, Tadic A, Mott R, Lieb K, Flint J. 2016. The amount of mitochondrial DNA in blood reflects the course of a depressive episode. Biol Psychiatry. 80:e41–e42.
   PubMed Web of Science ®Google Scholar
• Oral E, Canpolat S, Yildirim S, Gulec M, Aliyev E, Aydin N. 2012. Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder. Brain Res Bull. 88:454–459.
   PubMed Web of Science ®Google Scholar
• Piccinni A, Marazziti D, Del Debbio A, Bianchi C, Roncaglia I, Mannari C, Origlia N, Catena Dell'Osso M, Massimetti G, Domenici L, et al. 2008. Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences. Chronobiol Int. 25:819–826.
   PubMed Web of Science ®Google Scholar
• Polyakova M, Stuke K, Schuemberg K, Mueller K, Schoenknecht P, Schroeter ML. 2015. BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis. J Affect Disord. 174:432–440.
   PubMed Web of Science ®Google Scholar
• Reitan RM. 1979. Trail making test - manual for administration and scoring. Tuscon (Arizona): Reitan Neuropsychology Laboratory.
   Google Scholar
• Reppermund S, Ising M, Lucae S, Zihl J. 2009. Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis. Psychol Med. 39:603–614.
   PubMed Web of Science ®Google Scholar
• Reppermund S, Zihl J, Lucae S, Horstmann S, Kloiber S, Holsboer F, Ising M. 2007. Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation. Biol Psychiatry. 62:400–406.
   PubMed Web of Science ®Google Scholar
• Rudenko A, Tsai LH. 2014. Epigenetic modification in the nervous system nd their impact upon cognitive impairments. Neuropharmacology. 80:70–82.
   PubMed Web of Science ®Google Scholar
• Sen S, Duman R, Sanacora G. 2008. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 64:527–532.
   PubMed Web of Science ®Google Scholar
• Snyder HR. 2013. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull. 139:81–132.
   PubMed Web of Science ®Google Scholar
• Svenningsson P, Kim Y, Warner-Schmidt J, Oh YS, Greengard P. 2013. P11 and its role in depression and therapeutic responses to antidepressants. Nat Rev Neurosci 14:673–680.
   PubMed Web of Science ®Google Scholar
• Tadić A, Gorbulev S, Dahmen N, Hiemke C, Braus DF, Roschke J, van Calker D, Wachtlin D, Kronfeld K, Gorbauch T, et al. 2010. Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder - the EMC trial. Trials. 11:21.
   PubMed Web of Science ®Google Scholar
• Tadić A, Müller-Engling L, Schlicht KF, Kotsiari A, Dreimüller N, Kleimann A, Bleich S, Lieb K, Frieling H. 2014. Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression. Mol Psychiatry. 19:281–283.
   PubMed Web of Science ®Google Scholar
• Tadić A, Wachtlin D, Berger M, Braus DF, van Calker D, Dahmen N, Dreimüller N, Engel A, Gorbulev S, Helmreich I, et al. 2016. Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression-The EMC trial. Eur Neuropsychophar-macol. 26:705–716.
   PubMed Web of Science ®Google Scholar
• Tadić A, Wagner S, Schlicht KF, Peetz D, Borysenko L, Dreimüller N, Hiemke C, Lieb K. 2011. The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 35:415–420.
   PubMed Web of Science ®Google Scholar
• Taliaz D, Loya A, Gersner R, Haramati S, Chen A, Zangen A. 2011. Resilience to chronic stress is mediated by hippocampal brain-derived neurotrophic factor. J Neurosci 31:4475–4483.
   PubMed Web of Science ®Google Scholar
• Thomas AJ, Gallagher P, Robinson LJ, Porter RJ, Young AH, Ferrier IN, O'Brien JT. 2009. A comparison of neurocognitive impairment in younger and older adults with major depression. Psychol Med 39:725–733.
   PubMed Web of Science ®Google Scholar
• Tombaugh TN. 2004. Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 19:203–214.
   PubMed Web of Science ®Google Scholar
• Tombaugh TN, Kozak J, Rees L. 1999. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 14:167–177.
   PubMed Web of Science ®Google Scholar
• Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. 2006. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9:519–525.
   PubMed Web of Science ®Google Scholar
• Wagner S, Doering B, Helmreich I, Lieb K, Tadic A. 2012. A meta-analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment. Acta Psychiatr Scand 125:281–292.
   PubMed Web of Science ®Google Scholar
• Wagner S, Helmreich I, Lieb K, Tadic A. 2011a. Standardized rater training for the Hamilton Depression Rating Scale (HAMD-17) and the Inventory of Depressive Symptoms (IDS-C30). Psychopathology 44:68–70.
   PubMed Web of Science ®Google Scholar
• Wagner S, Helmreich I, Dahmen N, Lieb K, Tadic A. 2011. Reliability of three alternate forms of the trail making tests a and B. Arch Clin Neuropsychol 26:314–321.
   PubMed Web of Science ®Google Scholar
• Wagner S, Helmreich I, Wollschläger D, Meyer K, Kaaden S, Reiff J, et al. 2018. Early improvement of executive test performance during antidepressant treatment predicts treatment outcome in patients with major depressive disorder. PLoS One. Under revision.
   Web of Science ®Google Scholar
• Wang L, Ashley-Koch A, Steffens DC, Krishnan KRR, Taylor WD. 2012. Impact of BDNF Val66Met and 5-HTTLPR polymorphism variants on neural substrates related to sadness and executive function. Genes Brain Behav. 11:352–359.
   PubMed Web of Science ®Google Scholar
• Warner-Schmidt JL, Chen EY, Zhang X, Marshall JJ, Morozov A, Svenningsson P, Greengard P. 2010. A role for p11 in the antidepressant action of brain-derived neurotrophic factor. Biol Psychiatry. 68:528–535.
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Zaudig M, Fydrich T. 1996. SKID-I/-II: Strukturiertes klinisches Interview für DSM-IV. Göttingen: Hogrefe.
   Google Scholar
• Zheleznyakova GY, Cao H, Schioth HB. 2016. BDNF DNA methylation changes as a biomarker of psychiatric disorders: literature review and open access database analysis. Behav Brain Funct. 12:17.
   PubMed Web of Science ®Google Scholar